We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+9.88%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$25.8B
AUM Growth
+$4.56B
Cap. Flow
+$3.3B
Cap. Flow %
12.77%
Top 10 Hldgs %
19.43%
Holding
1,157
New
287
Increased
424
Reduced
242
Closed
147

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$997M
2
TXN icon
Texas Instruments
TXN
+$215M
3
NVDA icon
NVIDIA
NVDA
+$209M
4
VZ icon
Verizon
VZ
+$208M
5
APH icon
Amphenol
APH
+$143M

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$200M
2
MRUS
Merus
MRUS
+$158M
3
ALL icon
Allstate
ALL
+$141M
4
CB icon
Chubb
CB
+$115M
5
ARGX icon
argenx
ARGX
+$106M

Sector Composition

Rank Sector Weight
1 Healthcare 24.16%
2 Technology 23.32%
3 Financials 10.75%
4 Consumer Discretionary 10.22%
5 Communication Services 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRMM
726
Forum Markets
FRMM
$79.5M
$2.86M 0.01%
582,655
+262,537
+82% +$3.71M
LNT icon
727
Alliant Energy
LNT
$18B
$2.85M 0.01%
43,856
+9,895
+29% +$663K
EVRG icon
728
Evergy
EVRG
$19.2B
$2.85M 0.01%
39,277
+8,859
+29% +$672K
TPL icon
729
Texas Pacific Land
TPL
$23.5B
$2.84M 0.01%
9,893
+2,237
+29% +$683K
LNTH icon
730
Lantheus
LNTH
$6.59B
$2.82M 0.01%
42,382
T icon
731
AT&T
T
$163B
$2.8M 0.01%
112,894
-7,914,814
-99% -$200M
WST icon
732
West Pharmaceutical
WST
$24.9B
$2.78M 0.01%
10,088
-242,128
-96% -$66.2M
TSHA icon
733
Taysha Gene Therapies
TSHA
$1.89B
$2.75M 0.01%
500,000
CABA icon
734
Cabaletta Bio
CABA
$455M
$2.74M 0.01%
1,250,242
-885,106
-41% -$2.19M
J icon
735
Jacobs Solutions
J
$17B
$2.7M 0.01%
20,395
+4,597
+29% +$674K
ALGS icon
736
Aligos Therapeutics
ALGS
$34.6M
$2.7M 0.01%
289,169
-179,030
-38% -$1.69M
INVH icon
737
Invitation Homes
INVH
$18B
$2.68M 0.01%
+96,563
New +$2.7M
FIG
738
Figma
FIG
$12.4B
$2.62M 0.01%
70,000
FOXA icon
739
Fox Class A
FOXA
$26.9B
$2.6M 0.01%
+35,580
New +$2.32M
KMX icon
740
CarMax
KMX
$8.26B
$2.57M 0.01%
+66,386
New +$2.65M
ALB icon
741
Albemarle
ALB
$15.5B
$2.53M 0.01%
17,912
-152,564
-89% -$17.3M
SMCI icon
742
Super Micro Computer
SMCI
$20.1B
$2.52M 0.01%
86,173
-141,902
-62% -$5.84M
FFIV icon
743
F5
FFIV
$22.7B
$2.51M 0.01%
+9,838
New +$2.65M
JBHT icon
744
JB Hunt Transport Services
JBHT
$25.2B
$2.5M 0.01%
+12,875
New +$2.21M
PLRX icon
745
Pliant Therapeutics
PLRX
$65M
$2.47M 0.01%
2,026,191
-2,478,626
-55% -$3.72M
ATAI icon
746
AtaiBeckley Inc
ATAI
$2.68B
$2.45M 0.01%
+600,000
New +$2.83M
PGR icon
747
Progressive
PGR
$125B
$2.44M 0.01%
+10,724
New +$2.42M
SXT icon
748
Sensient Technologies
SXT
$5.53B
$2.42M 0.01%
+25,736
New +$2.43M
VLTO icon
749
Veralto
VLTO
$24B
$2.4M 0.01%
+24,092
New +$2.44M
MPWR icon
750
Monolithic Power Systems
MPWR
$68.9B
$2.39M 0.01%
+2,640
New +$2.54M

Similar funds

Woodline Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Woodline Partners held 1,157 positions worth $25.8B, up 21% from $21.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Woodline Partners deployed $3.3B of net new capital in Q4 2025, opening 287 new positions and adding to 424 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 1,467,676 shares worth $1.01B.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was AT&T, an estimated $200M trimmed.

  • Woodline Partners's largest Q4 2025 buy was iShares Core S&P 500 ETF: 1,467,676 shares worth $1.01B.
  • Woodline Partners added most to Texas Instruments in Q4 2025, an estimated $215M increase.
  • Woodline Partners's biggest Q4 2025 reduction was AT&T, cutting an estimated $200M.
  • Woodline Partners fully exited Merus in Q4 2025, selling an estimated $158M.
  • Woodline Partners's ten largest holdings make up 19% of its $25.8B portfolio in Q4 2025.
  • Woodline Partners opened 287 new positions and closed 147 in Q4 2025.
  • Woodline Partners's portfolio value rose 21% quarter-over-quarter to $25.8B.

Based on Woodline Partners's 13F filing for Q4 2025, filed 17 Feb 2026.